Waterloo Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Sell
2,971
-324
-10% -$69.8K 0.04% 270
2025
Q4
$677K Sell
3,295
-128
-4% -$24.1K 0.05% 254
2025
Q3
$537K Sell
3,423
-310
-8% -$47.9K 0.04% 266
2025
Q2
$627K Buy
3,733
+756
+25% +$112K 0.05% 237
2025
Q1
$410K Buy
+2,977
New +$379K 0.04% 278

Other funds holding CAH

Waterloo Capital's CAH Position: Q1 2026 in Review

Waterloo Capital reduced its Cardinal Health (CAH) stake by 9.8% in Q1 2026, selling an estimated $69.8K and leaving 2,971 shares worth $628K. The position accounts for 0.04% of the portfolio, ranked #270.

Waterloo Capital first reported a position in CAH in Q1 2025 and has held it in 5 quarters since. The position peaked at $677K in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Waterloo Capital held 2,971 shares of Cardinal Health worth $628K as of Q1 2026.
  • Waterloo Capital sold 324 Cardinal Health shares in Q1 2026, an estimated $69.8K.
  • Cardinal Health made up 0.04% of Waterloo Capital's portfolio in Q1 2026, its #270 holding.
  • Waterloo Capital first reported a position in Cardinal Health in Q1 2025 and has held it in 5 quarters since.
  • Waterloo Capital's Cardinal Health position peaked at $677K in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.